ESMO Sarcoma And Rare Cancers 2025

ESMO Sarcoma And Rare Cancers 2025

ESMO Sarcoma And Rare Cancers 2025 Great experience at the ESMO Sarcoma and Rare Cancers Congress 2025! Our Genomic and Trascriptomic team contributed 3 posters, 2 oral presentations, and an interview, focusing on our research in glioblastoma and...
Publication 14-03-2025

Publication 14-03-2025

Publication 14-03-2025 High-throughput drug sensitivity screening of cancer cell lines (CCLs) offers a promising avenue for discovering new anti-tumor therapies. In this study, we leverage large-scale datasets and cell line transcriptomics to predict drug responses,...
Publication 14-03-2025

Publication 10-03-2025

Publication 10-03-2025 Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at advanced stages, limiting treatment options and survival rates. Unlike other major cancers, no population-wide screening programs exist for PDAC, making early detection a critical but...